Streetbeat News

Stock Prices

MTRS

Metros Development Co., Ltd. (NASDAQ:MTRS) is set to IPO on March 08, offering shares at an expected price between $8.00 and $9.00. The company, a real estate consulting firm focusing on identifying and purchasing underdeveloped properties for resale to developers, has a 180-day insider lock-up period ending on September 04, 2024.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 3:00 pm

IMXUSD

Immutable's cryptocurrency (IMX) saw a 9.87% price increase over the last 24 hours to $3.26, despite a 3.0% decrease over the past week from $3.33. The coin's all-time high is $9.52. Trading volume decreased by 5.0% over the past week, with the circulating supply dropping to 1.39 billion, 69.46% of its max supply. IMX's market cap ranks #32 at $4.48 billion.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 3:00 pm

SJA

SolarJuice Co., Ltd. (NASDAQ:SJA) is set to IPO on March 08, offering shares between $4.00 and $6.00 with a 180-day insider lock-up period. The company specializes in solar PV energy solutions and roofing installation in Australia and the US.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 3:00 pm

CELZ

Trading of Creative Medical Technology Holdings, Inc. (CELZ) shares has resumed after a temporary halt. This development is crucial for investors monitoring the stock's performance.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:58 pm

RTO

Rentokil Initial (NYSE:RTO) reported FY23 adjusted EPS of $0.29, surpassing the $0.28 estimate, and sales of $6.69B, exceeding the $6.67B estimate. This represents an 8.71% increase in earnings and a 44.74% increase in sales from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:57 pm

OCEA

Trading of Ocean Biomedical shares has resumed.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:55 pm

MNMD

Mind Medicine Inc (NASDAQ:MNMD) shares surged after receiving FDA breakthrough therapy designation for its MM120 program for generalized anxiety disorder treatment and announcing positive Phase 2b study data. The study met its key secondary endpoint, showing significant durability of activity through week 12. Additionally, MindMed announced a share offering and private placement expected to close on March 11, aiming to raise approximately $175 million.

Portfolio Pulse from Adam Eckert

March 07, 2024 | 2:54 pm

APM

BJ

BREA

CDMO

CERO

LYT

SWIN

Nasdaq rose by 100 points as U.S. stocks traded higher, with BJ's Wholesale reporting weaker than expected sales for Q4 FY23. Materials and health care sectors saw gains, while Lytus Technologies, CERo Therapeutics, and Brera Holdings experienced significant stock increases. Conversely, Solowin Holdings, Aptorum Group, and Express, Inc. saw notable declines. Oil prices fell, while gold and copper prices increased.

Portfolio Pulse from Avi Kapoor

March 07, 2024 | 2:54 pm

OCEA

Shares of Ocean Biomedical were halted due to a circuit breaker after surging 30.9% to the upside, indicating a significant increase in the stock's value.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:54 pm

KR

Kroger Company (NYSE:KR) shares rose after reporting a 6.4% year-on-year sales growth for Q4 FY23, with $37.064 billion in sales, slightly below analyst expectations. Adjusted EPS of $1.34, excluding the 53rd week, beat the consensus of $1.13. Gross margin was 22.7%, and operating income increased by 44.5% to $1.2 billion. Kroger ended the quarter with $1.88 billion in cash and forecasts FY24 adjusted EPS of $4.30-$4.50. Shares are up 7.11% at $54.08.

Portfolio Pulse from Shivani Kumaresan

March 07, 2024 | 2:53 pm